Supreme Court Report

Supreme Court of the United States · Official docket →

Allergan, Inc., et al. v. Teva Pharmaceuticals USA, Inc., et al.

Paid petition · United States Court of Appeals for the Federal Circuit, No. 2018-1130 · judgment November 13, 2018

Certiorari denied · June 3, 2019
Pre-decision estimate: 2% cert probability

Before the decision, well below the 4.1% base rate, with no standout signals pointing toward a grant.

Question presented

  0,&+$(/:6+25( '($11$-5(,&+(/ &+5,6723+(5/(9$16 )LVK 5LFKDUGVRQ3& 6KRUH&KDQ'HSXPSR 5%&3OD]D //3 6RXWK6L[WK6WUHHW 0DLQ6WUHHW6XLWH 0LQQHDSROLV01    'DOODV7;    &RXQVHOIRU3HWLWLRQHU  $OOHUJDQ,QF &RXQVHOIRU3HWLWLRQHU 6DLQW5HJLV0RKDZN 7ULEH 686$1(0255,621  )LVK 5LFKDUGVRQ3& 'HODZDUH$YHQXH WK)ORRU :LOPLQJWRQ'(    &RXQVHOIRU3HWLWLRQHU $OOHUJDQ,QF

Counsel of record

For petitioner
Jonathan E. Singer
Fish & Richardson, P.C., P.A.

For respondent
Douglas H Carsten
McDermott Will & Emery LLP

Case

Conference history
Distributed for 1 conference

Proceedings

  1. Jun 03 2019
    Petition DENIED.
  2. May 14 2019
    DISTRIBUTED for Conference of 5/30/2019.
  3. May 07 2019
    Waiver of right of respondent Akorn, Inc. to respond filed.
  4. May 07 2019
    Waiver of right of respondents Mylan Pharmaceuticals Inc.; Mylan, Inc. to respond filed.
  5. May 07 2019
    Waiver of right of respondent Teva Pharmaceuticals USA, Inc. to respond filed.
  6. Apr 10 2019
    Petition for a writ of certiorari filed. (Response due May 10, 2019)